000 01279 a2200349 4500
005 20250517231101.0
264 0 _c20190923
008 201909s 0 0 eng d
022 _a1879-016X
024 7 _a10.1016/j.pharmthera.2018.07.003
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSoendergaard, Christoffer
245 0 0 _aTargeting JAK-STAT signal transduction in IBD.
_h[electronic resource]
260 _bPharmacology & therapeutics
_c12 2018
300 _a100-111 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aClinical Trials as Topic
650 0 4 _aCytokines
_xmetabolism
650 0 4 _aHumans
650 0 4 _aInflammatory Bowel Diseases
_xdrug therapy
650 0 4 _aJanus Kinase Inhibitors
_xadministration & dosage
650 0 4 _aJanus Kinases
_xantagonists & inhibitors
650 0 4 _aMolecular Targeted Therapy
650 0 4 _aSTAT Transcription Factors
_xmetabolism
650 0 4 _aSignal Transduction
700 1 _aBergenheim, Fredrik Holmberg
700 1 _aBjerrum, Jakob Tveiten
700 1 _aNielsen, Ole Haagen
773 0 _tPharmacology & therapeutics
_gvol. 192
_gp. 100-111
856 4 0 _uhttps://doi.org/10.1016/j.pharmthera.2018.07.003
_zAvailable from publisher's website
999 _c28672122
_d28672122